Inhibition of Type 1 Diabetes Development by Vitamin D Receptor Agonists

E-ISSN： 1875-6131|4|6|645-651

ISSN： 1568-0142

Source： Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol.4, Iss.6, 2005-12, pp. : 645-651

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?

Current Pharmaceutical Design, Vol. 21, Iss. 36, 2015-11 ,pp. : 5292-5298

Bentham Science Publishers

Access to resources Recommend Favorite

Novel GLP-1 receptor agonists for diabetes

By Garber Alan J

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 45-57

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors

By Holst Jens Juul

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 155-166

Informa Healthcare

Access to resources Recommend Favorite

A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes

By Montanya Eduard

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1451-1467

Informa Healthcare

Access to resources Recommend Favorite

Incretin therapy for type 2 diabetes: GLP-1 receptor agonists and DPP-4 inhibitors

By Ahrén Bo

European Diabetes Nursing, Vol. 10, Iss. 1, 2013-03 ,pp. : 31-36

Blackwell Publishing

Access to resources Recommend Favorite